ESC Professional Premium Access

Clinical characteristics, patient selection and clinical outcomes of tafamidis treatment in transthyretin amyloidosis cardiomyopathy

Congress Session

About the speaker

Doctor Seiji Takashio

Kumamoto University Hospital, Kumamoto (Japan)
0 follower

6 more presentations in this session

Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis - a retrospective Austrian multicenter study

Speaker: Doctor N. Verheyen (Graz, AT)

Thumbnail

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis

Speaker: Assistant Professor A. Briasoulis (Iowa City, US)

Thumbnail

Hypertension is associated with more advanced heart failure in african americans with suspected cardiac amyloidosis

Speaker: Doctor S. Manjunath (Saint Louis, US)

Thumbnail

Atrial fibrillation as a prognostic factor for all-cause mortality in patients with transthyretin amyloid cardiomyopathy

Speaker: Professor R. Witteles (Palo Alto, US)

Thumbnail

Histological validation of cardiac 99mTc-DPD uptake in patients with cardiac transthyretin amyloidosis

Speaker: Doctor M. Ungericht (Innsbruck, AT) Associate Professor G. Polzl (Innsbruck, AT)

Thumbnail

Access the full session

Chronic heart failure - Amyloidosis

Speakers: Doctor S. Takashio, Doctor N. Verheyen, Assistant Professor A. Briasoulis, Doctor S. Manjunath, Professor R. Witteles...
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk